Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Pharmaceuticals

    Pharmaceuticals - Page 300

    Sebi exempts trust linked to Alembic, Alembic Pharma from open offer requirement

    Sebi exempts trust linked to Alembic, Alembic Pharma from open offer requirement

    Ruby Khatun Khatun9 April 2018 11:00 AM IST
    New Delhi: Markets regulator Sebi has exempted a private family trust related to the promoter group of Alembic Pharmaceuticals and Alembic from making...
    Novartis to buy AveXis for 8.7 billion dollars gene therapy deal

    Novartis to buy AveXis for 8.7 billion dollars gene therapy deal

    Ruby Khatun Khatun9 April 2018 10:00 AM IST
    Novartis is moving further into gene therapy with an $8.7 billion deal for AveXis that gives the Swiss drugmaker a rare-disease treatment seen reaping...
    Glenmark recalls 100,000 bottles of anti-inflammatory drug over incorrect instrictions

    Glenmark recalls 100,000 bottles of anti-inflammatory drug over incorrect instrictions

    Ruby Khatun Khatun9 April 2018 10:00 AM IST
    New Delhi: Glenmark Pharmaceuticals is recalling over 100,000 bottles of anti-inflammatory Indomethacin capsules from the US market due to incorrect...
    Pharma sector likely to report weak numbers in Q4

    Pharma sector likely to report weak numbers in Q4

    Ruby Khatun Khatun9 April 2018 9:30 AM IST
    The troubled pharma sector is expected to report weak Q4 FY18 numbers, with PAT likely to decline by 9 percent (year-on-year) and appreciation in...
    Medical studies in humans often launched on faulty evidence base: Report

    Medical studies in humans often launched on faulty evidence base: Report

    Medical Dialogues Bureau8 April 2018 8:07 PM IST
    New research reveals serious flaws in the animal studies that regulators and ethicists use to decide if an experimental drug should be tested in...
    Boehringer Ingelheim partners with OSE Immunotherapeutics to develop pioneering checkpoint inhibitor for advanced solid tumors

    Boehringer Ingelheim partners with OSE Immunotherapeutics to develop pioneering checkpoint inhibitor for advanced solid tumors

    Ruby Khatun Khatun8 April 2018 9:45 AM IST
    Boehringer Ingelheim and OSE Immunotherapeutics, a biotechnology company focused on the development of innovative immunotherapies, announced a...
    Novo Nordisk buys blood drug licence to boost anaemic biopharma business

    Novo Nordisk buys blood drug licence to boost anaemic biopharma business

    Ruby Khatun Khatun8 April 2018 9:30 AM IST
    COPENHAGEN: Danish drugmaker Novo Nordisk has secured the global license for U.S. biotech company EpiDestiny’s sickle cell disease (SCD) program in a...
    Health ministry bans sale of 14 steroid creams sans doctor’s prescription

    Health ministry bans sale of 14 steroid creams sans doctor’s prescription

    Ruby Khatun Khatun7 April 2018 2:10 PM IST
    New Delhi: Through a recent gazette notification, Ministry of Health And Family Welfare has banned the over-the-counter (OTC) sale of 14 steroid-based...
    Lupin gets EIR from USFDA for Pithampur facility

    Lupin gets EIR from USFDA for Pithampur facility

    Ruby Khatun Khatun7 April 2018 10:30 AM IST
    New Delhi: Drug firm Lupin said it has received an Establishment Inspection Report (EIR) from the US health regulator for its Pithampur, Unit 1...
    Natco launches generic version of multiple sclerosis drug in India

    Natco launches generic version of multiple sclerosis drug in India

    Ruby Khatun Khatun7 April 2018 10:00 AM IST
    New Delhi: Drug firm Natco Pharma said it has launched a generic version of Teriflunomide tablets used for the treatment of relapsing and remitting...
    AbbVie, Samsung Bioepis in deal, Humira biosimilar US release in 2023

    AbbVie, Samsung Bioepis in deal, Humira biosimilar US release in 2023

    Ruby Khatun Khatun7 April 2018 9:30 AM IST
    AbbVie Inc said it signed a deal with Samsung Bioepis and its joint venture partner Biogen Inc that would fend off U.S. competition of their...
    Johnson and Johnson loses trial over claims linking cancer to asbestos in talc

    Johnson and Johnson loses trial over claims linking cancer to asbestos in talc

    Ruby Khatun Khatun7 April 2018 9:30 AM IST
    Johnson and Johnson suffered its first trial loss in a lawsuit claiming its talc-based products including Johnson’s Baby Powder contain cancer-causing...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    FDC Ban: Avoid These Combinations of Paracetamol

    FDC Ban: Avoid These Combinations of Paracetamol

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Relief to Lupin: High court removes ban its diabetes drug Gluconorm P 30

    Relief to Lupin: High court removes ban its diabetes drug Gluconorm P 30

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok